Literature DB >> 33139300

Insights into Tumor-Associated Tertiary Lymphoid Structures: Novel Targets for Antitumor Immunity and Cancer Immunotherapy.

Anthony B Rodriguez1,2, Victor H Engelhard3,2.   

Abstract

Tertiary lymphoid structures (TLS) are ectopic lymphoid aggregates that phenotypically resemble conventional secondary lymphoid organs and are commonly found at sites of chronic inflammation. They are also found in a wide variety of primary and metastatic human tumors. The presence of tumor-associated TLS (TA-TLS) is associated with prolonged patient survival, higher rates of disease-free survival, and a favorable response to current cancer therapies. However, the immune responses that occur in these structures, and how they contribute to improved clinical outcomes, remain incompletely understood. In addition, it is unknown how heterogeneity in TA-TLS cellular composition, structural organization, and anatomic location influences their functionality and prognostic significance. Understanding more about TA-TLS development, formation, and function may offer new therapeutic options to modulate antitumor immunity. ©2020 American Association for Cancer Research.

Entities:  

Year:  2020        PMID: 33139300      PMCID: PMC7643396          DOI: 10.1158/2326-6066.CIR-20-0432

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  74 in total

1.  The dynamics of the T-cell antitumor response: chemokine-secreting dendritic cells can prime tumor-reactive T cells extranodally.

Authors:  C J Kirk; D Hartigan-O'Connor; J J Mulé
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

2.  Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures.

Authors:  Marie-Caroline Dieu-Nosjean; Martine Antoine; Claire Danel; Didier Heudes; Marie Wislez; Virginie Poulot; Nathalie Rabbe; Ludivine Laurans; Eric Tartour; Luc de Chaisemartin; Serge Lebecque; Wolf-Herman Fridman; Jacques Cadranel
Journal:  J Clin Oncol       Date:  2008-09-20       Impact factor: 44.544

3.  Prognostic Significance of Tumor-Infiltrating Lymphocytes and the Tertiary Lymphoid Structures in HER2-Positive Breast Cancer Treated With Adjuvant Trastuzumab.

Authors:  Hee Jin Lee; Joo Young Kim; In Ah Park; In Hye Song; Jong Han Yu; Jin-Hee Ahn; Gyungyub Gong
Journal:  Am J Clin Pathol       Date:  2015-08       Impact factor: 2.493

4.  Tertiary lymphoid structures: prognostic significance and relationship with tumour-infiltrating lymphocytes in triple-negative breast cancer.

Authors:  Hee Jin Lee; In Ah Park; In Hye Song; Su-Jin Shin; Joo Young Kim; Jong Han Yu; Gyungyub Gong
Journal:  J Clin Pathol       Date:  2015-10-16       Impact factor: 3.411

5.  Dendritic cells in tumor-associated tertiary lymphoid structures signal a Th1 cytotoxic immune contexture and license the positive prognostic value of infiltrating CD8+ T cells.

Authors:  Jérémy Goc; Claire Germain; Thi Kim Duy Vo-Bourgais; Audrey Lupo; Christophe Klein; Samantha Knockaert; Luc de Chaisemartin; Hanane Ouakrim; Etienne Becht; Marco Alifano; Pierre Validire; Romain Remark; Scott A Hammond; Isabelle Cremer; Diane Damotte; Wolf-Herman Fridman; Catherine Sautès-Fridman; Marie-Caroline Dieu-Nosjean
Journal:  Cancer Res       Date:  2013-12-23       Impact factor: 12.701

6.  De novo induction of intratumoral lymphoid structures and vessel normalization enhances immunotherapy in resistant tumors.

Authors:  Anna Johansson-Percival; Bo He; Zhi-Jie Li; Alva Kjellén; Karen Russell; Ji Li; Irma Larma; Ruth Ganss
Journal:  Nat Immunol       Date:  2017-09-11       Impact factor: 25.606

7.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

8.  12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?

Authors:  Jane L Messina; David A Fenstermacher; Steven Eschrich; Xiaotao Qu; Anders E Berglund; Mark C Lloyd; Michael J Schell; Vernon K Sondak; Jeffrey S Weber; James J Mulé
Journal:  Sci Rep       Date:  2012-10-24       Impact factor: 4.379

9.  Extranodal induction of therapeutic immunity in the tumor microenvironment after intratumoral delivery of Tbet gene-modified dendritic cells.

Authors:  L Chen; J L Taylor; N C Sabins; D B Lowe; Y Qu; Z You; W J Storkus
Journal:  Cancer Gene Ther       Date:  2013-07-12       Impact factor: 5.987

10.  Tertiary Lymphoid Structures Associate with Tumour Stage in Urothelial Bladder Cancer.

Authors:  Madhuri Koti; Amanda Shou Xu; Kevin Yi Mi Ren; Kash Visram; Runhan Ren; David M Berman; D Robert Siemens
Journal:  Bladder Cancer       Date:  2017-10-27
View more
  14 in total

1.  Tertiary lymphoid structure patterns predicted anti-PD1 therapeutic responses in gastric cancer.

Authors:  Quan Jiang; Chenyu Tian; Hao Wu; Lingqiang Min; Hao Chen; Lingli Chen; Fenglin Liu; Yihong Sun
Journal:  Chin J Cancer Res       Date:  2022-08-30       Impact factor: 4.026

Review 2.  Insights into tertiary lymphoid structures in the solid tumor microenvironment: anti-tumor mechanism, functional regulation, and immunotherapeutic strategies.

Authors:  Hua Zhao; Hao Wang; Qiuru Zhou; Xiubao Ren
Journal:  Cancer Biol Med       Date:  2021-09-24       Impact factor: 5.347

Review 3.  Role of tertiary lymphoid organs in the regulation of immune responses in the periphery.

Authors:  Amit I Bery; Hailey M Shepherd; Wenjun Li; Alexander S Krupnick; Andrew E Gelman; Daniel Kreisel
Journal:  Cell Mol Life Sci       Date:  2022-06-11       Impact factor: 9.207

Review 4.  Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy.

Authors:  Shota Aoyama; Ryosuke Nakagawa; James J Mulé; Adam W Mailloux
Journal:  Front Immunol       Date:  2021-05-14       Impact factor: 7.561

5.  Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.

Authors:  Anthony B Rodriguez; J David Peske; Amber N Woods; Katie M Leick; Ileana S Mauldin; Max O Meneveau; Samuel J Young; Robin S Lindsay; Marit M Melssen; Salwador Cyranowski; Geoffrey Parriott; Mark R Conaway; Yang-Xin Fu; Craig L Slingluff; Victor H Engelhard
Journal:  Cell Rep       Date:  2021-07-20       Impact factor: 9.995

6.  Case Report: Sarcoid-Like Reactions and Tertiary Lymphoid Structures Following Dual Checkpoint Inhibition in a Patient with Early-Stage Lung Adenocarcinoma.

Authors:  Xiaoliang Zhao; Dongsheng Yue; Juanjuan Qian; Lei Zhang; Jin Song; Bin Zhang; Chunmei Zhang; Leina Sun; Yuchen Ma; Henghui Zhang; Changli Wang
Journal:  Front Immunol       Date:  2022-01-31       Impact factor: 7.561

7.  Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma.

Authors:  Azaz Ahmed; Sophia Köhler; Rosa Klotz; Nathalia Giese; Thilo Hackert; Christoph Springfeld; Inka Zörnig; Dirk Jäger; Niels Halama
Journal:  Oncoimmunology       Date:  2022-01-31       Impact factor: 7.723

8.  Unique characteristics of tertiary lymphoid structures in kidney clear cell carcinoma: prognostic outcome and comparison with bladder cancer.

Authors:  Tsukasa Masuda; Nobuyuki Tanaka; Kimiharu Takamatsu; Kyohei Hakozaki; Ryohei Takahashi; Tadatsugu Anno; Ryohei Kufukihara; Kazunori Shojo; Shuji Mikami; Toshiaki Shinojima; Kazuhiro Kakimi; Tatsuhiko Tsunoda; Eriko Aimono; Hiroshi Nishihara; Ryuichi Mizuno; Mototsugu Oya
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 12.469

Review 9.  High endothelial venules (HEVs) in immunity, inflammation and cancer.

Authors:  Lucas Blanchard; Jean-Philippe Girard
Journal:  Angiogenesis       Date:  2021-05-06       Impact factor: 9.596

Review 10.  Tumor-Associated Tertiary Lymphoid Structures: From Basic and Clinical Knowledge to Therapeutic Manipulation.

Authors:  Charlotte Domblides; Juliette Rochefort; Clémence Riffard; Marylou Panouillot; Géraldine Lescaille; Jean-Luc Teillaud; Véronique Mateo; Marie-Caroline Dieu-Nosjean
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.